# Oxytocin And Uterotonic Agent Use For Cesarean Delivery

> **NCT01549223** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 60 (actual)

## Conditions studied

- Uterine Atony
- Hypotension

## Interventions

- **DRUG:** Oxytocin Infusion
- **DRUG:** Oxytocin Bolus

## Key facts

- **NCT ID:** NCT01549223
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01549223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01549223, "Oxytocin And Uterotonic Agent Use For Cesarean Delivery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01549223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*